Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

AC Immune (ACIU) Other Operating Expenses (2016 - 2026)

AC Immune has reported Other Operating Expenses over the past 11 years, most recently at $14047.1 for Q1 2026.

  • Quarterly Other Operating Expenses rose 1362.94% to $14047.1 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $139203.4 through Mar 2026, up 69.48% year-over-year, with the annual reading at $117610.0 for FY2025, 27.44% down from the prior year.
  • Other Operating Expenses was $14047.1 for Q1 2026 at AC Immune, down from $91335.4 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $497009.0 in Q1 2022 and troughed at -$1112.3 in Q1 2025.
  • The 5-year median for Other Operating Expenses is $153131.0 (2025), against an average of $209386.3.
  • Year-over-year, Other Operating Expenses crashed 101.43% in 2025 and then soared 1362.94% in 2026.
  • A 5-year view of Other Operating Expenses shows it stood at $414170.7 in 2022, then decreased by 3.37% to $400210.8 in 2023, then plummeted by 96.01% to $15981.3 in 2024, then skyrocketed by 471.51% to $91335.4 in 2025, then plummeted by 84.62% to $14047.1 in 2026.
  • Per Business Quant, the three most recent readings for ACIU's Other Operating Expenses are $14047.1 (Q1 2026), $91335.4 (Q4 2025), and $33820.9 (Q2 2025).